Home > Vivo Capital acquires VYNE Therapeutics Inc.
Transaction · Life Science

Vivo Capital acquires VYNE Therapeutics Inc.

Vivo Capital acquired VYNE Therapeutics Inc., a life science company in California, United States.

Deal at a glance

TargetVYNE Therapeutics Inc. Buyer Vivo Capital SectorLife Science LocationCalifornia, United States ValueNot disclosed

Target company

VYNE Therapeutics Inc.
California, United States
Life Sciencesector
2011founded
Activestatus
View the company profile →

Buyer

Company · 20 deals on record
20deals, all time
14in this sector
2021latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired VYNE Therapeutics Inc.?Vivo Capital acquired VYNE Therapeutics Inc..

What type of deal was it?It was a transaction in the life science sector.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).